G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Pr. 100-let Vladivostoku 159, 690022 Vladivostok, Russia.
Department of Bioorganic Chemistry and Biotechnology, School of Natural Sciences, Far Eastern Federal University, Russky Island, Ajax Bay, 10, 690922 Vladivostok, Russia.
Mar Drugs. 2024 Jun 26;22(7):294. doi: 10.3390/md22070294.
Three new monosulfated polyhydroxysteroid glycosides, spiculiferosides A (), B (), and C (), along with new related unsulfated monoglycoside, spiculiferoside D (), were isolated from an ethanolic extract of the starfish collected in the Sea of Okhotsk. Compounds - contain two carbohydrate moieties, one of which is attached to C-3 of the steroid tetracyclic core, whereas another is located at C-24 of the side chain of aglycon. Two glycosides (, ) are biosides, and one glycoside (), unlike them, includes three monosaccharide residues. Such type triosides are a rare group of polar steroids of sea stars. In addition, the 5-substituted 3-OSO-α-L-Araf unit was found in steroid glycosides from starfish for the first time. Cell viability analysis showed that - (at concentrations up to 100 μM) had negligible cytotoxicity against human embryonic kidney HEK293, melanoma SK-MEL-28, breast cancer MDA-MB-231, and colorectal carcinoma HCT 116 cells. These compounds significantly inhibited proliferation and colony formation in HCT 116 cells at non-toxic concentrations, with compound having the greatest effect. Compound exerted anti-proliferative effects on HCT 116 cells through the induction of dose-dependent cell cycle arrest at the G2/M phase, regulation of expression of cell cycle proteins CDK2, CDK4, cyclin D1, p21, and inhibition of phosphorylation of protein kinases c-Raf, MEK1/2, ERK1/2 of the MAPK/ERK1/2 pathway.
从在鄂霍次克海采集的海星中用乙醇提取得到三个新的单硫酸化多羟基甾醇糖苷,分别为 spiculiferosides A ()、B () 和 C (),以及一个新的相关非硫酸化单糖苷 spiculiferoside D ()。化合物 - 含有两个糖基部分,其中一个连接在甾体四环核心的 C-3 上,另一个位于糖苷配基侧链的 C-24 上。两个糖苷(,)是生物苷,而另一个糖苷()则不同,它包含三个单糖残基。这种类型的三糖苷是海星中一类罕见的极性甾体。此外,在海星甾体糖苷中首次发现了 5-取代的 3-OSO-α-L-Araf 单元。细胞活力分析表明,-(浓度高达 100 μM)对人胚肾 HEK293、黑色素瘤 SK-MEL-28、乳腺癌 MDA-MB-231 和结直肠癌细胞 HCT 116 几乎没有细胞毒性。这些化合物在非毒性浓度下显著抑制 HCT 116 细胞的增殖和集落形成,其中化合物 具有最大的作用。化合物 通过诱导细胞周期阻滞在 G2/M 期,调节细胞周期蛋白 CDK2、CDK4、cyclin D1、p21 的表达,并抑制 MAPK/ERK1/2 途径中的蛋白激酶 c-Raf、MEK1/2、ERK1/2 的磷酸化,对 HCT 116 细胞发挥抗增殖作用。